131st Meeting of the National Advisory Council on Drug Abuse
Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.
Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event, should contact Gillian Acca via email or phone at 301-827-5843 or through the Federal Relay (1-800-877-8339). Requests should be made at least five days in advance of the workshop.
February 13, 2019
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
| 9:00 a.m. |
Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA |
| 9:15 a.m. |
Council Review of Grant Applications
Division of Neuroscience and Behavior (DNB) |
| 10:15 a.m. | Break |
Videocast: https://videocast.nih.gov/summary.asp?live=31483
Open Session
| 10:30 a.m. |
Welcome and Opening Remarks Nora Volkow, M.D. Director, NIDA |
| 10:45 a.m. |
Director's Report Nora Volkow, M.D. Director, NIDA |
| 11:45 a.m. |
Discussion Council Members |
| 12:15 p.m. | Lunch Break |
| 1:30 p.m. |
HHS Efforts to Combat the Opioid Crisis ADM Brett Giroir, M.D., Assistant Secretary for Health, U.S. Department of Health and Human Services |
| 2:10 p.m. |
Changing the Culture to Address Sexual Harassment Carrie Wolinetz, Ph.D., Associate Director for Science Policy, NIH |
| 2:40 p.m. |
Neural Circuit Dynamics of Brain States and Drug Action Karl Deisseroth, M.D., Ph.D., D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences Stanford University and NACDA Member |
| 3:15 p.m. |
Concept Clearances
|
| 4:15 p.m. | Public Comments |
| 4:30 p.m. | Adjourn |